Maryland Heights, MO, March 17, 2017 --(PR.com
)-- The global in vitro diagnostics market to reach nearly USD 82.7 Billion in 2020, at a CAGR of 6.5% from 2016 to 2020, due to fast, accurate and non-invasive technologies worldwide.
Browse In Vitro Diagnostics Market by Clinical Applications (Blood Testing, Clinical Chemistry, Diabetes Testing, Immunoassay, Molecular Diagnostics) 2016-2020 at https://www.ihealthcareanalyst.com/report/in-vitro-diagnostics-market/
In Vitro Diagnostics (IVD) is an important segment in the global healthcare industry. The diagnostic tests that can detect diseases, conditions, or infections. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home. Technological advancements, better diagnostic tools, and improved treatment monitoring, and increased availability of over-the-counter tests are mainly driving the global in vitro diagnostics market. In vitro diagnostics provide valuable information regarding the physiological and/or pathological state of the body and therefore are essential to make well-informed medical decisions. In vitro diagnostic products are those reagents, instruments, and systems intended for use in diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae. Such products are intended for use in the collection, preparation, and examination of specimens taken from the human body.
The global in vitro diagnostics market is segmented by clinical applications (blood testing, clinical chemistry, diabetes testing, immunoassay, molecular diagnostics).
The global in vitro diagnostics market report estimates the market size (Revenue USD million - 2013 to 2020) and composition of this market and also forecasts growth trends (CAGR% - 2016 to 2020). The global in vitro diagnostics market research report is further segmented by geography North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global in vitro diagnostics market report also provides the detailed market landscape, market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.
Major players operating in the global in vitro diagnostics market and included in this report are Abbott Laboratories Inc., Alere Inc., Bayer AG, Becton Dickinson and Company, Biomerieux SA, Beckman Coulter Inc., Danaher Corporation, Gen-Probe Incorporated, Johnson and Johnson, Life Technologies Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare (a division of Siemens AG) and Thermo Fisher Scientific Corporation.
To request Table of Contents and Sample Pages of this report visit:
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043